Impact of Hormone Therapy on Ocular Disease Risk in Postmenopausal Women: Evidence from the Korean National Health Insurance Service Database.

While a lower incidence of glaucoma was noted in women aged 50–59 years who used MHT for ≥ 365 days compared to those with shorter duration (IRR 0.914, 95% CI [0.814, 1.026]), the difference did not reach statistical significance.

also in 111,027 other papers